The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R03 | Drugs for obstructive airway diseases | |
| 3 | R03A | Adrenergics, inhalants | |
| 4 | R03AL | Adrenergics in combination with anticholinergics | |
| 5 | R03AL07 |
| Active Ingredient | Description | |
|---|---|---|
| Formoterol and Glycopyrronium bromide |
Combination of two bronchodilators: glycopyrronium, a long-acting muscarinic antagonist (also referred to as an anticholinergic), and formoterol, a long-acting β2-adrenergic agonist with a rapid onset of action. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BEVESPI AEROSPHERE Pressurised inhalation, suspension | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
